154 related articles for article (PubMed ID: 29367704)
1. Association of metreleptin treatment and dietary intervention with neurological outcomes in Celia's encephalopathy.
Araújo-Vilar D; Domingo-Jiménez R; Ruibal Á; Aguiar P; Ibáñez-Micó S; Garrido-Pumar M; Martínez-Olmos MÁ; López-Soler C; Guillín-Amarelle C; González-Rodríguez M; Rodríguez-Núñez A; Álvarez-Escudero J; Liñares-Paz M; González-Méndez B; Rodríguez-García S; Sánchez-Iglesias S
Eur J Hum Genet; 2018 Mar; 26(3):396-406. PubMed ID: 29367704
[TBL] [Abstract][Full Text] [Related]
2. Skipped BSCL2 Transcript in Celia's Encephalopathy (PELD): New Insights on Fatty Acids Involvement, Senescence and Adipogenesis.
Sánchez-Iglesias S; Unruh-Pinheiro A; Guillín-Amarelle C; González-Méndez B; Ruiz-Riquelme A; Rodríguez-Cañete BL; Rodríguez-García S; Guillén-Navarro E; Domingo-Jiménez R; Araújo-Vilar D
PLoS One; 2016; 11(7):e0158874. PubMed ID: 27391332
[TBL] [Abstract][Full Text] [Related]
3. Celia's encephalopathy and c.974dupG in BSCL2 gene: a hidden change in a known variant.
Sánchez-Iglesias S; Crocker M; O'Callaghan M; Darling A; García-Cazorla A; Domingo-Jiménez R; Castro A; Fernández-Pombo A; Ruibal Á; Aguiar P; Garrido-Pumar M; Rodríguez-Núñez A; Álvarez-Escudero J; Brown RJ; Araújo-Vilar D
Neurogenetics; 2019 May; 20(2):73-82. PubMed ID: 30903322
[TBL] [Abstract][Full Text] [Related]
4. A murine model of BSCL2-associated Celia's encephalopathy.
Cobelo-Gómez S; Sánchez-Iglesias S; Rábano A; Senra A; Aguiar P; Gómez-Lado N; García-Varela L; Burgueño-García I; Lampón-Fernández L; Fernández-Pombo A; Díaz-López EJ; Prado-Moraña T; San Millán B; Araújo-Vilar D
Neurobiol Dis; 2023 Oct; 187():106300. PubMed ID: 37717662
[TBL] [Abstract][Full Text] [Related]
5. Larger aggregates of mutant seipin in Celia's Encephalopathy, a new protein misfolding neurodegenerative disease.
Ruiz-Riquelme A; Sánchez-Iglesias S; Rábano A; Guillén-Navarro E; Domingo-Jiménez R; Ramos A; Rosa I; Senra A; Nilsson P; García Á; Araújo-Vilar D; Requena JR
Neurobiol Dis; 2015 Nov; 83():44-53. PubMed ID: 26282322
[TBL] [Abstract][Full Text] [Related]
6. Celia's Encephalopathy (
Sánchez-Iglesias S; Fernández-Pombo A; Cobelo-Gómez S; Hermida-Ameijeiras Á; Alarcón-Martínez H; Domingo-Jiménez R; Ruíz Riquelme AI; Requena JR; Araújo-Vilar D
J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33916074
[TBL] [Abstract][Full Text] [Related]
7. Metreleptin for the treatment of progressive encephalopathy with/without lipodystrophy (PELD) in a child with progressive myoclonic epilepsy: a case report.
Pedicelli S; de Palma L; Pelosini C; Cappa M
Ital J Pediatr; 2020 Oct; 46(1):158. PubMed ID: 33099310
[TBL] [Abstract][Full Text] [Related]
8. Role of Seipin in Human Diseases and Experimental Animal Models.
Li Y; Yang X; Peng L; Xia Q; Zhang Y; Huang W; Liu T; Jia D
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740965
[TBL] [Abstract][Full Text] [Related]
9. Does Seipin Play a Role in Oxidative Stress Protection and Peroxisome Biogenesis? New Insights from Human Brain Autopsies.
Sánchez-Iglesias S; Fernández-Liste A; Guillín-Amarelle C; Rábano A; Rodriguez-Cañete L; González-Méndez B; Fernández-Pombo A; Senra A; Araújo-Vilar D
Neuroscience; 2019 Jan; 396():119-137. PubMed ID: 30447390
[TBL] [Abstract][Full Text] [Related]
10. Whole Exome Sequencing Reveals a BSCL2 Mutation Causing Progressive Encephalopathy with Lipodystrophy (PELD) in an Iranian Pediatric Patient.
Alaei MR; Talebi S; Ghofrani M; Taghizadeh M; Keramatipour M
Iran Biomed J; 2016 Nov; 20(5):295-301. PubMed ID: 27452399
[TBL] [Abstract][Full Text] [Related]
11. Leptin replacement therapy but not dietary polyunsaturated fatty acid alleviates HIV protease inhibitor-induced dyslipidemia and lipodystrophy in mice.
Riddle TM; Fichtenbaum CJ; Hui DY
J Acquir Immune Defic Syndr; 2003 Aug; 33(5):564-70. PubMed ID: 12902799
[TBL] [Abstract][Full Text] [Related]
12. Metreleptin Treatment in a Boy with Congenital Generalized Lipodystrophy due to Homozygous c.465_468delGACT (p.T156Rfs*8) Mutation in the
Özalkak Ş; Demiral M; Ünal E; Taş FF; Onay H; Demirbilek H; Özbek MN
J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):329-333. PubMed ID: 35735786
[TBL] [Abstract][Full Text] [Related]
13. Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy.
Brown RJ; Valencia A; Startzell M; Cochran E; Walter PJ; Garraffo HM; Cai H; Gharib AM; Ouwerkerk R; Courville AB; Bernstein S; Brychta RJ; Chen KY; Walter M; Auh S; Gorden P
J Clin Invest; 2018 Aug; 128(8):3504-3516. PubMed ID: 29723161
[TBL] [Abstract][Full Text] [Related]
14. Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin.
Diker-Cohen T; Cochran E; Gorden P; Brown RJ
J Clin Endocrinol Metab; 2015 May; 100(5):1802-10. PubMed ID: 25734254
[TBL] [Abstract][Full Text] [Related]
15. Update on Therapeutic Options in Lipodystrophy.
Akinci B; Meral R; Oral EA
Curr Diab Rep; 2018 Oct; 18(12):139. PubMed ID: 30370487
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy.
Chan JL; Koda J; Heilig JS; Cochran EK; Gorden P; Oral EA; Brown RJ
Clin Endocrinol (Oxf); 2016 Jul; 85(1):137-49. PubMed ID: 26589105
[TBL] [Abstract][Full Text] [Related]
17. A new seipin-associated neurodegenerative syndrome.
Guillén-Navarro E; Sánchez-Iglesias S; Domingo-Jiménez R; Victoria B; Ruiz-Riquelme A; Rábano A; Loidi L; Beiras A; González-Méndez B; Ramos A; López-González V; Ballesta-Martínez MJ; Garrido-Pumar M; Aguiar P; Ruibal A; Requena JR; Araújo-Vilar D
J Med Genet; 2013 Jun; 50(6):401-9. PubMed ID: 23564749
[TBL] [Abstract][Full Text] [Related]
18. Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives.
Tchang BG; Shukla AP; Aronne LJ
Expert Opin Biol Ther; 2015 Jul; 15(7):1061-75. PubMed ID: 26063386
[TBL] [Abstract][Full Text] [Related]
19. Metreleptin worked in a diabetic woman with a history of hematopoietic stem cell transplantation (HSCT) during infancy: further support for the concept of 'HSCT-associated lipodystrophy'.
Adachi M; Muroya K; Hanakawa J; Asakura Y
Endocr J; 2021 Apr; 68(4):399-407. PubMed ID: 33229817
[TBL] [Abstract][Full Text] [Related]
20. W(h)ither metreleptin for lipodystrophy and the metabolic syndrome?
Mantzoros CS
Endocr Pract; 2010; 16(2):162-6. PubMed ID: 20350904
[No Abstract] [Full Text] [Related]
[Next] [New Search]
